Page 88 - IJB-8-2
P. 88

RESEARCH ARTICLE

           3D-printed Bioresorbable Stent Coated with

           Dipyridamole-Loaded Nanofiber for Restenosis

           Prevention and Endothelialization


           Chengjin Wang  1,2,3 , Yang Yang 1,2,3 , Jingyuan Ji 1,2,3 , Yongcong Fang , Liliang Ouyang 1,2,3 ,
                                                                            1,2
           Lei Zhang 1,2,3 *, Wei Sun 1,2,3,4 *

           1 Biomanufacturing Center, Department of Mechanical Engineering, Tsinghua University, Beijing 100084, China
           2 Biomanufacturing and Rapid Forming Technology Key Laboratory of Beijing, Beijing 100084, China
           3 “Biomanufacturing and Engineering Living Systems” Innovation International Talents Base (111 Base), Beijing 100084, China
           4 Department of Mechanical Engineering, Drexel University, Philadelphia, PA 19104, USA

           Abstract: Intimal hyperplasia and restenosis caused by excessive proliferation of smooth muscle cells (SMC) are the main
           factors for the failure of stent implantation. Drug-eluting stents carried with antiproliferative drugs have emerged as a successful
           approach  to  alleviate  early  neointimal  development.  However,  these  agents  have  been  reported  to  have  an  undesirable
           effect on re-endothelialization. In this study, we proposed an integrated bioresorbable stent coated with dipyridamole (DP)-
           loaded  poly(D,L-lactide)  (PDLLA)  nanofibers.  Three-dimensional  (3D)  bioresorbable  stents  were  fabricated  by  printing
           on a rotation mandrel using polycaprolactone (PCL), and the stents were further coated with PDLLA/DP nanofibers. The
           in vitro degradation and drug release evaluation illustrated the potential for long-term release of DP. Stents coated with
           PDLLA/DP nanofibers showed excellent hemocompatibility. The cell viability, proliferation, and morphology analysis results
           revealed that stents coated with PDLLA/DP nanofibers could prevent the proliferation of SMC and have no adverse effects on
           endothelial cells. The in vivo implantation of stents coated with PDLLA/DP nanofibers showed initial patency and continuous
           endothelialization and alleviated neointimal formation. The attractive in vitro and in vivo performance indicated its potential
           for restenosis prevention and endothelialization.
           Keywords: Bioresorbable stent; Nanofiber; Dipyridamole; Anti-restenosis; Endothelialization

           *Correspondence to: Lei Zhang, Biomanufacturing Center, Department of Mechanical Engineering, Tsinghua University, Beijing 100084, China;
           stoneszhang@mail.tsinghua.edu.cn; Wei Sun, Biomanufacturing Center, Department of Mechanical Engineering, Tsinghua University, Beijing
           100084, China; weisun@mail.tsinghua.edu.cn
           Received: January 13, 2022; Accepted: February 19, 2022; Published Online: February 19, 2022
           (This article belongs to the Special Issue: Composite/Multi-component Biomaterial Inks and Bioinks)

           Citation: Wang, C., Yang, Y., Ji, J., et al., 2022, 3D-Printed Bioresorbable Stent Coated with Dipyridamole-Loaded Nanofiber for Restenosis
           Prevention and Endothelialization. Int J Bioprint, 8(2):543. http://doi.org/10.18063/ijb.v8i2.543

           1. Introduction                                     and  prolonged  dual  antiplatelet  therapy [3,4] .  Moreover,
                                                               antiproliferative agents loaded in the polymer coating of
           In recent years, metallic drug-eluting stents (DES) have
           become an effective clinical treatment for coronary artery   DES, such as sirolimus and paclitaxel, have been reported
           disease,  which  work  by  introducing  antiproliferative   to  have  an  undesirable  effect  on  re-endothelialization,
           drug-loaded  polymer  coatings  that  can  inhibit  smooth   which may result in long-term endothelial dysfunction [5,6] .
           muscle cell (SMC) proliferation and alleviate neointimal   To overcome the inherent drawbacks of permanently
           development [1,2] .  However,  residual  metallic  stents  as   existing  metallic  stents,  bioresorbable  stents  have  been
           foreign objects would cage the vessel permanently, leading   developed  to provide temporary support with tunable
           to late stent thrombosis, impaired coronary vasomotion,   degradation  rates  of  stent  materials .  Bioresorbable
                                                                                               [7]
           © 2022 Author(s). This is an Open Access article distributed under the terms of the Creative Commons Attribution License, permitting distribution and
           reproduction in any medium, provided the original work is properly cited.
           80
   83   84   85   86   87   88   89   90   91   92   93